Home › Funds › RATIONAL ADVISORS, INC. › HALO

RATIONAL ADVISORS, INC. position in HALO

HALOZYME THERAPEUTICS INC · Health Care

RATIONAL ADVISORS, INC. reported holding 6,310,000 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$9.0M, representing 0.85% of its reported portfolio and ranking #28 among its reported holdings. RATIONAL ADVISORS, INC. has disclosed HALO holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)6.31M sh
Reported value held$8.98M
Portfolio Weight0.85%
First reportedQ4 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How RATIONAL ADVISORS, INC.'s HALO position evolved

RATIONAL ADVISORS, INC. first disclosed a stake in HALO in Q4 2025 at 2,440,000 shares (US$2.6M). The position peaked in Q3 2026 at 6,310,000 shares, worth US$9.0M. Across 4 filings, RATIONAL ADVISORS, INC. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,310,000 shares valued at US$9.0M — an increase of 1,200,000 shares quarter over quarter.. Notable position changes include a 72% increase in Q2 2026 (shares rose 41% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 2.44M $2.63M New
Q1 2026 2.97M $3.08M Add
Q2 2026 5.11M $5.68M Add
Q3 2026 6.31M $8.98M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HALO and 13F data

HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in HALO — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$251.9M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$178.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HALO

All HALO fund holders →

FAQ

How long has RATIONAL ADVISORS, INC. held HALO?

RATIONAL ADVISORS, INC. has disclosed HALO holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is RATIONAL ADVISORS, INC.'s current position in HALO?

As of Q3 2026, RATIONAL ADVISORS, INC. holds 6.31M shares of HALO (HALOZYME THERAPEUTICS INC), valued at $8.98M, representing 0.85% of its reported portfolio and ranking #28.

Has RATIONAL ADVISORS, INC. been buying or selling HALO?

In the latest 13F filing (Q3 2026), RATIONAL ADVISORS, INC. increased its position in HALO. The position peaked in Q3 2026 at 6.31M shares.

Which other funds hold HALO?

Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, SNYDER CAPITAL MANAGEMENT L P, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.